Abortion Drug Law in Louisiana Heightens Hemorrhage Risk for Pregnant Patients
KFF Health News · C · trust 50/100
A 2024 state law reclassified misoprostol and mifepristone as controlled substances. That affects how hospitals can access the drugs in non-abortion emergencies, and other states appear to be taking note.
Read the original at KFF Health News →
Open in TruthVane →